Verve Therapeutics, Inc.
NASDAQ:VERV
6.24 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 206.18 | 115.412 | 64.33 | 8.993 | 2.986 |
| Short Term Investments
| 417.77 | 439.396 | 296.112 | 63.119 | 15.796 |
| Cash and Short Term Investments
| 623.95 | 554.808 | 360.442 | 72.112 | 18.782 |
| Net Receivables
| 5.897 | 1.012 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 8.102 | 7.339 | 13.372 | 1.854 | 0.272 |
| Total Current Assets
| 637.949 | 563.159 | 367.128 | 73.966 | 19.054 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 107.8 | 110.655 | 9.063 | 3.984 | 2.358 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 4.824 | 5.237 | 0.463 | 0.235 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.939 | 0.585 | 2.696 | 0 | 0 |
| Total Non-Current Assets
| 114.739 | 116.064 | 16.996 | 4.447 | 2.593 |
| Total Assets
| 752.688 | 679.223 | 384.124 | 78.413 | 21.647 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 6.636 | 2.424 | 7.077 | 0.036 | 2.411 |
| Short Term Debt
| 10.192 | 23.808 | 3.91 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 20.014 | -12.992 | 0.09 | 0.031 |
| Other Current Liabilities
| 20.178 | 8.863 | 11.037 | 7.189 | 1.111 |
| Total Current Liabilities
| 37.006 | 35.095 | 22.024 | 7.315 | 3.553 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 64.715 | 70.014 | 0 | 125.16 | 35.051 |
| Deferred Revenue Non-Current
| 48.556 | 20.014 | 0 | 0.125 | 0.132 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -125.285 | -35.183 |
| Other Non-Current Liabilities
| 2.909 | 3.168 | 4.748 | 9.722 | 2.464 |
| Total Non-Current Liabilities
| 116.18 | 93.196 | 4.748 | 135.007 | 37.647 |
| Total Liabilities
| 153.186 | 128.291 | 26.772 | 142.322 | 41.2 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 384.124 | 125.16 | 25.48 |
| Common Stock
| 0.082 | 0.062 | 0.049 | 0.003 | 0.002 |
| Retained Earnings
| -544.305 | -344.237 | -186.85 | -66.536 | -20.832 |
| Accumulated Other Comprehensive Income/Loss
| 0.272 | -0.694 | -0.228 | 0.008 | 0.009 |
| Other Total Stockholders Equity
| 1,143.453 | 895.801 | 544.381 | 2.616 | 1.268 |
| Total Shareholders Equity
| 599.502 | 550.932 | 357.352 | -63.909 | -19.553 |
| Total Equity
| 599.502 | 550.932 | 357.352 | -63.909 | -19.553 |
| Total Liabilities & Shareholders Equity
| 752.688 | 679.223 | 384.124 | 78.413 | 21.647 |